DE69127045T2 - Histamin-h3-rezeptor-agonisten zur therapeutischen anwendung, pharmazeutische zubereitungen, die an h3-rezeptoren-agonistisch wirken, un die methode ihrer darstellung - Google Patents
Histamin-h3-rezeptor-agonisten zur therapeutischen anwendung, pharmazeutische zubereitungen, die an h3-rezeptoren-agonistisch wirken, un die methode ihrer darstellungInfo
- Publication number
- DE69127045T2 DE69127045T2 DE69127045T DE69127045T DE69127045T2 DE 69127045 T2 DE69127045 T2 DE 69127045T2 DE 69127045 T DE69127045 T DE 69127045T DE 69127045 T DE69127045 T DE 69127045T DE 69127045 T2 DE69127045 T2 DE 69127045T2
- Authority
- DE
- Germany
- Prior art keywords
- histamine
- pct
- compounds
- receptor
- therapeutic use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9005776A FR2661909B1 (fr) | 1990-05-09 | 1990-05-09 | Nouveaux composes agonistes du recepteur h3 de l'histamine a usage therapeutique, compositions pharmaceutiques agissant comme agonistes dudit recepteur et procede de preparation. |
PCT/FR1991/000384 WO1991017146A1 (fr) | 1990-05-09 | 1991-05-10 | Nouveaux composes agonistes du recepteur h3 de l'histamine a usage therapeutique, compositions pharmaceutiques agissant comme agonistes dudit recepteur et procede de preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69127045D1 DE69127045D1 (de) | 1997-09-04 |
DE69127045T2 true DE69127045T2 (de) | 1998-03-05 |
Family
ID=9396429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69127045T Expired - Lifetime DE69127045T2 (de) | 1990-05-09 | 1991-05-10 | Histamin-h3-rezeptor-agonisten zur therapeutischen anwendung, pharmazeutische zubereitungen, die an h3-rezeptoren-agonistisch wirken, un die methode ihrer darstellung |
Country Status (11)
Country | Link |
---|---|
US (1) | US5342960A (de) |
EP (1) | EP0482183B1 (de) |
JP (1) | JP3094384B2 (de) |
AT (1) | ATE156121T1 (de) |
CA (1) | CA2063550C (de) |
DE (1) | DE69127045T2 (de) |
DK (1) | DK0482183T3 (de) |
ES (1) | ES2107464T3 (de) |
FR (1) | FR2661909B1 (de) |
GR (1) | GR3024991T3 (de) |
WO (1) | WO1991017146A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5633250A (en) * | 1991-12-18 | 1997-05-27 | Schering Corporation | Imidazoylalkyl substituted with a six or seven membered heterocyclic ring containing two nitrogen atoms |
EP0618905B1 (de) * | 1991-12-18 | 1995-10-04 | Schering Corporation | Imidazolylalkyl- piperazin und -diazepin derivate als histamin h3 agonisten/antagonisten |
US5486526A (en) * | 1992-04-01 | 1996-01-23 | The University Of Toledo | Histamine H3 -receptor antagonists and therapeutic uses thereof |
US5639775A (en) * | 1992-04-01 | 1997-06-17 | The University Of Toledo | 4-[4'-piperodinyl or 3'-pirrolidinyl] substituted imidazoles as H3 -receptor antagonists and therapeutic uses thereof |
EP0633882A1 (de) * | 1992-04-01 | 1995-01-18 | The University Of Toledo | 4-(4'piperidinyl oder 3'-pyrrolidinyl) substituierte imidazole als h3-rezeptor-antagonisten und ihre therapeutische verwendung |
US6407132B1 (en) | 1997-07-25 | 2002-06-18 | James Black Foundation Limited | Substituted imidazole derivatives and their use as histamine H3 receptor ligands |
JP2000189171A (ja) * | 1998-12-25 | 2000-07-11 | Banyu Pharmaceut Co Ltd | 新規なグアノシン三リン酸(gtp)結合タンパク質共役型のレセプタ―タンパク質 |
EP1147092A1 (de) | 1999-01-18 | 2001-10-24 | Novo Nordisk A/S | Substituierte imidazole, ihre herstellung und verwendung |
US6908926B1 (en) | 1999-04-16 | 2005-06-21 | Novo Nordisk A/S | Substituted imidazoles, their preparation and use |
US6437147B1 (en) | 2000-03-17 | 2002-08-20 | Novo Nordisk | Imidazole compounds |
US6610721B2 (en) | 2000-03-17 | 2003-08-26 | Novo Nordisk A/S | Imidazo heterocyclic compounds |
EP1505074A4 (de) * | 2002-04-24 | 2005-12-21 | Banyu Pharma Co Ltd | Konstitutiv aktive mutanten eines histamin h3 rezeptors und deren verwendungen |
AP2007004161A0 (en) | 2005-04-28 | 2007-10-31 | Pfizer Ltd | Amino acid derivatives |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT71653B (en) * | 1979-08-15 | 1982-01-21 | Merck & Co Inc | Process for preparing allylsulfoxide enzyme inhibitor |
FR2548183B1 (fr) * | 1983-07-01 | 1985-10-31 | Synthelabo | Diphenylazomethines portant un radical imidazolyle, leur preparation et leur application en therapeutique |
NL8501093A (nl) * | 1985-04-12 | 1986-11-03 | Stamicarbon | Werkwijze voor het racemiseren van een optisch aktief n- benzylideenaminozuuramide. |
FR2586562B1 (fr) * | 1985-09-02 | 1989-03-10 | Inst Nat Sante Rech Med | Composition pharmaceutique contenant de l'a-methylhistamine |
FR2630328B1 (fr) * | 1988-04-22 | 1990-08-24 | Inst Nat Sante Rech Med | Derive de l'histamine, sa preparation et son application en therapeutique |
-
1990
- 1990-05-09 FR FR9005776A patent/FR2661909B1/fr not_active Expired - Fee Related
-
1991
- 1991-05-10 CA CA002063550A patent/CA2063550C/en not_active Expired - Lifetime
- 1991-05-10 WO PCT/FR1991/000384 patent/WO1991017146A1/fr active IP Right Grant
- 1991-05-10 ES ES91910312T patent/ES2107464T3/es not_active Expired - Lifetime
- 1991-05-10 JP JP03509563A patent/JP3094384B2/ja not_active Expired - Lifetime
- 1991-05-10 DE DE69127045T patent/DE69127045T2/de not_active Expired - Lifetime
- 1991-05-10 DK DK91910312.7T patent/DK0482183T3/da active
- 1991-05-10 AT AT91910312T patent/ATE156121T1/de not_active IP Right Cessation
- 1991-05-10 EP EP91910312A patent/EP0482183B1/de not_active Expired - Lifetime
- 1991-05-10 US US07/828,936 patent/US5342960A/en not_active Expired - Lifetime
-
1997
- 1997-10-09 GR GR970402634T patent/GR3024991T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69127045D1 (de) | 1997-09-04 |
FR2661909B1 (fr) | 1997-08-14 |
EP0482183B1 (de) | 1997-07-30 |
CA2063550C (en) | 2002-02-26 |
US5342960A (en) | 1994-08-30 |
DK0482183T3 (da) | 1998-03-09 |
JPH06501241A (ja) | 1994-02-10 |
GR3024991T3 (en) | 1998-01-30 |
ES2107464T3 (es) | 1997-12-01 |
FR2661909A1 (fr) | 1991-11-15 |
WO1991017146A1 (fr) | 1991-11-14 |
ATE156121T1 (de) | 1997-08-15 |
EP0482183A1 (de) | 1992-04-29 |
CA2063550A1 (en) | 1991-11-10 |
JP3094384B2 (ja) | 2000-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69127045T2 (de) | Histamin-h3-rezeptor-agonisten zur therapeutischen anwendung, pharmazeutische zubereitungen, die an h3-rezeptoren-agonistisch wirken, un die methode ihrer darstellung | |
YU38795A (sh) | Kortikotropinski otpuštajući faktor antagonisti, postupci za njihovo dobijanje i njihove farmaceutske smese | |
AU2614995A (en) | Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies | |
IT1282353B1 (it) | Composizione farmaceutica, in particolare liquida, per sommanistrazione orale di ondansetron e metodi per la sua produzione | |
MX9801305A (es) | Composicion de disolucion rapida oral para agonistas de dopamina. | |
MY114698A (en) | A process for the isolation of galanthamine | |
SE9303627D0 (sv) | Method and means for prevention of cataract | |
PL314188A1 (en) | Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions | |
DE69532580D1 (de) | Neue antagonistische verbindungen | |
FI972434A (fi) | Lamotrigiiniä sisältävä farmaseuttinen koostumus | |
DE69433012D1 (de) | Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac | |
FI932388A (fi) | 8-en-19,11b-bryggsteroider, deras framstaellning och farmaceutiska preparat innehaollande dem | |
HUT61467A (en) | Process for producing pharmaceutical compositions comprising quisqualate receptor antagonist quinoxalinedione and suitable for treating parkinson's disease | |
EP0344980A3 (de) | Alpha-adrenergische Rezeptorantagonisten | |
EP0344979A3 (de) | Alpha-adrenergische Rezeptorantagonisten | |
IL108283A0 (en) | Use of riluzole for promoting restoration following radiation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |